• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Israel-Based Evogene Establishes US Headquarters In St. Louis, Missouri

Israeli biotechnology company Evogene will establish its United States headquarters at the Bio-Research & Development Growth Park in St. Louis, Missouri. Evogene’s expansion includes a $1 million capital investment and is expected to create 15 new high-paying jobs in the next three years.

"The establishment of this new facility will clearly take Evogene to a new level in the important area of insect control. We are very proud to join BRDG Park and the innovative community in St. Louis. Being a company that is committed to the improvement of crop productivity, we share the Danforth Center’s belief that plants hold the key to discoveries and products that will enrich and restore both the environment and the lives of people around the globe," said Ofer Haviv, President/CEO of Evogene.

“Home to the largest concentration of plant scientists in the world and the second most farms in the nation, Missouri continues to attract more and more bioscience companies and researchers that work to improve and protect our food,” said Governor Jay Nixon. “I welcome Evogene to the Show-Me State and look forward to building on Missouri’s reputation as a bioscience powerhouse.”

To assist Evogene with its expansion to Creve Coeur, the Missouri Department of Economic Development has offered a strategic economic incentive package that the company can receive if it meets strict job creation and investment criteria. The Missouri Partnership also assisted with the company’s expansion.


Exclusive Research